COVID-19: Implications for Business
Rightfully labelled as a human tragedy, the spread of Coronavirus (COVID-19) has forced us to think and act differently. Beyond the human response, now is the time to think about what the consequences may be for your business, and how best you can prepare for those.
Corporate and M&A - View Our Insights
We examine the impact of COVID-19 on Hong Kong corporate law and outline some helpful suggestions for listed and private companies.
We examine the impact on the Hong Kong education market to date, outline some likely trends and provide our top tips for dealing with the impact.
We examine the impact of COVID-19 on the Hong Kong M&A market, outline some likely trends and provide our top tips for dealing with the impact.
Finance and Restructuring - View Our Insights
We look at the impact of coronavirus on finance transactions under English and Australian law, and put forward some practical suggestions.
Funds and Private Equity - View Our Insights
We sum up the effects of COVID-19 on private fundraising activities, with our advice for fund managers on the innovations for fundraising.
Labour and Employment - View Our Insights
We gathered senior lawyers, thought leaders and innovators for a discussion around how they move into a new phase of conducting their businesses.
We explore the rights and obligations of both employers and employees from an employment law perspective during the coronavirus outbreak.
Regulatory - View Our Insights
The Financial Action Task Force published a paper on the potential money laundering and terrorist financing risks and the necessary responses.
We sum up the joint statement of the SFC and HKEX on restrictions arising from the Coronavirus Outbreak.
We outline practical steps that businesses should consider taking for business continuity and regulatory compliance in such tumultuous times.
We sum up the SFC's guidance to intermediaries in response to the effects of the COVID-19 pandemic.
Securities & Capital Markets - View Our Insights
We examine the SEC guidance on the reasons for disclosing the impact on an issuer’s business of the COVID-19 pandemic.
We continue to examine the SEC guidance on the reasons for disclosing the impact on an issuer’s business of the COVID-19 pandemic.